Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | cathepsin F (C01 family) | 0.0017 | 0.0596 | 0.0596 |
Leishmania major | cathepsin L-like protease | 0.0065 | 0.4047 | 1 |
Echinococcus granulosus | cathepsin L cysteine proteinase | 0.0017 | 0.0596 | 0.0614 |
Schistosoma mansoni | NADPH flavin oxidoreductase | 0.0026 | 0.1254 | 0.1254 |
Entamoeba histolytica | type A flavoprotein, putative | 0.002 | 0.08 | 0.358 |
Trypanosoma brucei | cysteine peptidase, Clan CA, family C1, Cathepsin L-like | 0.0065 | 0.4047 | 1 |
Echinococcus granulosus | cathepsin l1 | 0.0017 | 0.0596 | 0.0614 |
Trichomonas vaginalis | NADPH cytochrome P450, putative | 0.002 | 0.08 | 0.257 |
Schistosoma mansoni | ap endonuclease | 0.0019 | 0.0747 | 0.0747 |
Trichomonas vaginalis | NADPH cytochrome P450, putative | 0.002 | 0.08 | 0.257 |
Plasmodium falciparum | S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase, putative | 0.002 | 0.08 | 0.257 |
Trypanosoma brucei | cysteine peptidase, Clan CA, family C1, Cathepsin L-like | 0.0065 | 0.4047 | 1 |
Plasmodium falciparum | cysteine proteinase falcipain 2b | 0.0017 | 0.0596 | 0.1914 |
Brugia malayi | Cathepsin L-like precursor | 0.0017 | 0.0596 | 0.0596 |
Plasmodium falciparum | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0019 | 0.0747 | 0.24 |
Echinococcus granulosus | NADPH dependent diflavin oxidoreductase 1 | 0.0052 | 0.3112 | 0.3208 |
Loa Loa (eye worm) | cysteine protease | 0.0017 | 0.0596 | 0.0414 |
Trichomonas vaginalis | Clan CA, family C1, papain-like cysteine peptidase | 0.0017 | 0.0596 | 0.1914 |
Trichomonas vaginalis | Clan CA, family C1, cathepsin L-like cysteine peptidase | 0.0017 | 0.0596 | 0.1914 |
Trichomonas vaginalis | ap endonuclease, putative | 0.0019 | 0.0747 | 0.24 |
Trypanosoma brucei | NADPH--cytochrome P450 reductase, putative | 0.0052 | 0.3112 | 0.7689 |
Trichomonas vaginalis | NADPH cytochrome P450, putative | 0.002 | 0.08 | 0.257 |
Plasmodium vivax | flavodoxin domain containing protein | 0.0046 | 0.2686 | 0.8632 |
Trypanosoma brucei | cysteine peptidase, Clan CA, family C1, Cathepsin L-like | 0.0065 | 0.4047 | 1 |
Trypanosoma cruzi | major cysteine proteinase, putative | 0.0051 | 0.3046 | 0.7525 |
Echinococcus multilocularis | cathepsin L cysteine protease | 0.0017 | 0.0596 | 0.0596 |
Echinococcus granulosus | methionine synthase reductase | 0.0032 | 0.168 | 0.1731 |
Onchocerca volvulus | 0.0017 | 0.0596 | 1 | |
Leishmania major | cytochrome P450 reductase, putative | 0.0046 | 0.2686 | 0.6057 |
Brugia malayi | Cathepsin L-like precursor | 0.0017 | 0.0596 | 0.0596 |
Trypanosoma brucei | cysteine peptidase, Clan CA, family C1, Cathepsin L-like | 0.0065 | 0.4047 | 1 |
Trypanosoma brucei | cysteine peptidase, Clan CA, family C1, Cathepsin L-like | 0.0065 | 0.4047 | 1 |
Trypanosoma cruzi | cytochrome P450 reductase, putative | 0.0052 | 0.3112 | 0.7689 |
Trichomonas vaginalis | Clan CA, family C1, cathepsin L-like cysteine peptidase | 0.0017 | 0.0596 | 0.1914 |
Schistosoma mansoni | gcn5proteinral control of amino-acid synthesis 5-like 2 gcnl2 | 0.0148 | 1 | 1 |
Trypanosoma cruzi | cysteine peptidase, clan CA, family C1, cathepsin L-like, putative | 0.006 | 0.3641 | 0.8997 |
Leishmania major | p450 reductase, putative | 0.0052 | 0.3112 | 0.729 |
Onchocerca volvulus | 0.0017 | 0.0596 | 1 | |
Trichomonas vaginalis | NADPH fad oxidoreductase, putative | 0.0046 | 0.2686 | 0.8632 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease | 0.0019 | 0.0747 | 0.1845 |
Echinococcus multilocularis | methionine synthase reductase | 0.0032 | 0.168 | 0.168 |
Brugia malayi | Cathepsin L-like precursor | 0.0017 | 0.0596 | 0.0596 |
Loa Loa (eye worm) | ctsf protein | 0.0017 | 0.0596 | 0.0414 |
Leishmania major | cathepsin L-like protease | 0.0065 | 0.4047 | 1 |
Trichomonas vaginalis | Clan CA, family C1, cathepsin L or K-like cysteine peptidase | 0.0017 | 0.0596 | 0.1914 |
Trichomonas vaginalis | Clan CA, family C1, cathepsin L or K-like cysteine peptidase | 0.0017 | 0.0596 | 0.1914 |
Treponema pallidum | flavodoxin | 0.002 | 0.08 | 1 |
Schistosoma mansoni | 5-methyl tetrahydrofolate-homocysteine methyltransferase reductase | 0.0032 | 0.168 | 0.168 |
Trichomonas vaginalis | Clan CA, family C1, papain-like cysteine peptidase | 0.0017 | 0.0596 | 0.1914 |
Trichomonas vaginalis | Clan CA, family C1, cathepsin L-like cysteine peptidase | 0.0011 | 0.019 | 0.0609 |
Onchocerca volvulus | 0.0017 | 0.0596 | 1 | |
Giardia lamblia | Hypothetical protein | 0.0046 | 0.2686 | 1 |
Trypanosoma brucei | cysteine peptidase, Clan CA, family C1, Cathepsin L-like | 0.0065 | 0.4047 | 1 |
Echinococcus multilocularis | cathepsin L cysteine protease | 0.0017 | 0.0596 | 0.0596 |
Loa Loa (eye worm) | hypothetical protein | 0.0052 | 0.3112 | 0.2979 |
Entamoeba histolytica | cysteine proteinase, putative | 0.0017 | 0.0596 | 0.2666 |
Plasmodium vivax | histone acetyltransferase GCN5, putative | 0.0044 | 0.2494 | 0.8015 |
Trichomonas vaginalis | ap endonuclease, putative | 0.0019 | 0.0747 | 0.24 |
Trypanosoma brucei | cysteine peptidase, Clan CA, family C1, Cathepsin L-like | 0.0065 | 0.4047 | 1 |
Loa Loa (eye worm) | acetyltransferase | 0.0148 | 1 | 1 |
Brugia malayi | Cathepsin L-like cysteine proteinase | 0.0011 | 0.019 | 0.019 |
Entamoeba histolytica | cysteine proteinase, putative | 0.0017 | 0.0596 | 0.2666 |
Loa Loa (eye worm) | papain family cysteine protease containing protein | 0.0017 | 0.0596 | 0.0414 |
Brugia malayi | Cathepsin L-like precursor | 0.0011 | 0.019 | 0.019 |
Echinococcus granulosus | histone acetyltransferase KAT2B | 0.0144 | 0.9702 | 1 |
Echinococcus multilocularis | NADPH dependent diflavin oxidoreductase 1 | 0.0052 | 0.3112 | 0.3112 |
Trichomonas vaginalis | Clan CA, family C1, papain-like cysteine peptidase | 0.0017 | 0.0596 | 0.1914 |
Trypanosoma cruzi | cytochrome P450 reductase, putative | 0.0052 | 0.3112 | 0.7689 |
Toxoplasma gondii | flavodoxin domain-containing protein | 0.0026 | 0.1225 | 0.3317 |
Trichomonas vaginalis | Clan CA, family C1, cathepsin L-like cysteine peptidase | 0.0017 | 0.0596 | 0.1914 |
Echinococcus multilocularis | DNA (apurinic or apyrimidinic site) lyase | 0.0019 | 0.0747 | 0.0747 |
Brugia malayi | Cathepsin L-like precursor | 0.0011 | 0.019 | 0.019 |
Echinococcus granulosus | histone acetyltransferase KAT2B | 0.0044 | 0.2494 | 0.2571 |
Trypanosoma cruzi | cysteine peptidase, putative | 0.0065 | 0.4047 | 1 |
Trichomonas vaginalis | sulfite reductase, putative | 0.0052 | 0.3112 | 1 |
Mycobacterium ulcerans | formate dehydrogenase H FdhF | 0.0052 | 0.3112 | 1 |
Onchocerca volvulus | Cathepsin L homolog | 0.0017 | 0.0596 | 1 |
Trichomonas vaginalis | Clan CA, family C1, cathepsin L-like cysteine peptidase | 0.0017 | 0.0596 | 0.1914 |
Loa Loa (eye worm) | hypothetical protein | 0.0017 | 0.0596 | 0.0414 |
Leishmania major | hypothetical protein, conserved | 0.002 | 0.08 | 0.0591 |
Echinococcus granulosus | NADPH cytochrome P450 reductase | 0.0052 | 0.3112 | 0.3208 |
Giardia lamblia | Histone acetyltransferase GCN5 | 0.004 | 0.2234 | 0.7666 |
Trypanosoma brucei | cysteine peptidase, Clan CA, family C1, Cathepsin L-like | 0.0065 | 0.4047 | 1 |
Trichomonas vaginalis | Clan CA, family C1, cathepsin L-like cysteine peptidase | 0.0017 | 0.0596 | 0.1914 |
Trichomonas vaginalis | Clan CA, family C1, papain-like cysteine peptidase | 0.0017 | 0.0596 | 0.1914 |
Chlamydia trachomatis | sulfite reductase | 0.0032 | 0.168 | 0.5 |
Leishmania major | apurinic/apyrimidinic endonuclease-redox protein | 0.0019 | 0.0747 | 0.0438 |
Brugia malayi | FAD binding domain containing protein | 0.0032 | 0.168 | 0.168 |
Entamoeba histolytica | cysteine protease, putative | 0.0017 | 0.0596 | 0.2666 |
Echinococcus multilocularis | cathepsin l cysteine peptidase | 0.0017 | 0.0596 | 0.0596 |
Trichomonas vaginalis | Clan CA, family C1, cathepsin L-like cysteine peptidase | 0.0011 | 0.019 | 0.0609 |
Plasmodium falciparum | histone acetyltransferase GCN5 | 0.004 | 0.2234 | 0.7177 |
Loa Loa (eye worm) | FAD binding domain-containing protein | 0.0052 | 0.3112 | 0.2979 |
Trichomonas vaginalis | Clan CA, family C1, papain-like cysteine peptidase | 0.0017 | 0.0596 | 0.1914 |
Trypanosoma cruzi | cysteine peptidase, putative | 0.0065 | 0.4047 | 1 |
Trichomonas vaginalis | bromodomain-containing protein, putative | 0.0044 | 0.2494 | 0.8015 |
Brugia malayi | exodeoxyribonuclease III family protein | 0.0019 | 0.0747 | 0.0747 |
Trypanosoma brucei | cysteine peptidase, Clan CA, family C1, Cathepsin L-like | 0.0065 | 0.4047 | 1 |
Schistosoma mansoni | cathepsin F (C01 family) | 0.0011 | 0.019 | 0.019 |
Trichomonas vaginalis | Clan CA, family C1, papain-like cysteine peptidase | 0.0017 | 0.0596 | 0.1914 |
Trichomonas vaginalis | Clan CA, family C1, cathepsin L-like cysteine peptidase | 0.0017 | 0.0596 | 0.1914 |
Trichomonas vaginalis | Clan CA, family C1, cathepsin L-like cysteine peptidase | 0.0017 | 0.0596 | 0.1914 |
Brugia malayi | Cathepsin L-like precursor | 0.0017 | 0.0596 | 0.0596 |
Brugia malayi | flavodoxin family protein | 0.0052 | 0.3112 | 0.3112 |
Toxoplasma gondii | exonuclease III APE | 0.0019 | 0.0747 | 0.0797 |
Entamoeba histolytica | type A flavoprotein, putative | 0.002 | 0.08 | 0.358 |
Toxoplasma gondii | histone lysine acetyltransferase GCN5-B | 0.0044 | 0.2494 | 1 |
Plasmodium vivax | vivapain-2 | 0.0017 | 0.0596 | 0.1914 |
Entamoeba histolytica | exodeoxyribonuclease III, putative | 0.0019 | 0.0747 | 0.3344 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease, putative | 0.0019 | 0.0747 | 0.1845 |
Trypanosoma brucei | NADPH--cytochrome P450 reductase, putative | 0.0052 | 0.3112 | 0.7689 |
Plasmodium falciparum | cysteine proteinase falcipain 3 | 0.0017 | 0.0596 | 0.1914 |
Schistosoma mansoni | cytochrome P450 reductase | 0.0052 | 0.3112 | 0.3112 |
Schistosoma mansoni | ap endonuclease | 0.0019 | 0.0747 | 0.0747 |
Trypanosoma brucei | cysteine peptidase, Clan CA, family C1, Cathepsin L-like | 0.0065 | 0.4047 | 1 |
Echinococcus multilocularis | cysteine protease | 0.0017 | 0.0596 | 0.0596 |
Echinococcus granulosus | DNA apurinic or apyrimidinic site lyase | 0.0019 | 0.0747 | 0.077 |
Schistosoma mansoni | cathepsin F (C01 family) | 0.0017 | 0.0596 | 0.0596 |
Entamoeba histolytica | acetyltransferase, GNAT family | 0.004 | 0.2234 | 1 |
Plasmodium falciparum | cysteine proteinase falcipain 2a | 0.0017 | 0.0596 | 0.1914 |
Onchocerca volvulus | 0.0017 | 0.0596 | 1 | |
Trichomonas vaginalis | Clan CA, family C1, cathepsin L-like cysteine peptidase | 0.0017 | 0.0596 | 0.1914 |
Trypanosoma cruzi | Flavodoxin/Radical SAM superfamily/Wyosine base formation, putative | 0.002 | 0.08 | 0.1976 |
Trichomonas vaginalis | Clan CA, family C1, papain-like cysteine peptidase | 0.0017 | 0.0596 | 0.1914 |
Leishmania major | NADPH-cytochrome p450 reductase-like protein | 0.0052 | 0.3112 | 0.729 |
Trypanosoma brucei | cysteine peptidase, Clan CA, family C1, Cathepsin L-like | 0.0065 | 0.4047 | 1 |
Brugia malayi | Cathepsin L-like precursor | 0.0017 | 0.0596 | 0.0596 |
Brugia malayi | Cathepsin L-like precursor | 0.0017 | 0.0596 | 0.0596 |
Trypanosoma brucei | NADPH-dependent diflavin oxidoreductase 1 | 0.0052 | 0.3112 | 0.7689 |
Onchocerca volvulus | 0.0017 | 0.0596 | 1 | |
Trichomonas vaginalis | Clan CA, family C1, cathepsin L-like cysteine peptidase | 0.0017 | 0.0596 | 0.1914 |
Trypanosoma cruzi | p450 reductase, putative | 0.0052 | 0.3112 | 0.7689 |
Onchocerca volvulus | Cathepsin L homolog | 0.0017 | 0.0596 | 1 |
Trichomonas vaginalis | Clan CA, family C1, cathepsin L-like cysteine peptidase | 0.0017 | 0.0596 | 0.1914 |
Schistosoma mansoni | diflavin oxidoreductase | 0.0026 | 0.1225 | 0.1225 |
Trichomonas vaginalis | Clan CA, family C1, papain-like cysteine peptidase | 0.0017 | 0.0596 | 0.1914 |
Trypanosoma brucei | NADPH-cytochrome p450 reductase, putative | 0.0052 | 0.3112 | 0.7689 |
Wolbachia endosymbiont of Brugia malayi | exonuclease III | 0.0019 | 0.0747 | 0.5 |
Toxoplasma gondii | histone lysine acetyltransferase GCN5-A | 0.0044 | 0.2494 | 1 |
Loa Loa (eye worm) | fibroinase | 0.0017 | 0.0596 | 0.0414 |
Entamoeba histolytica | type A flavoprotein, putative | 0.002 | 0.08 | 0.358 |
Leishmania major | cathepsin L-like protease | 0.0065 | 0.4047 | 1 |
Toxoplasma gondii | flavodoxin domain-containing protein | 0.0026 | 0.1225 | 0.3317 |
Entamoeba histolytica | type A flavoprotein, putative | 0.002 | 0.08 | 0.358 |
Trypanosoma cruzi | Flavodoxin/Radical SAM superfamily/Wyosine base formation, putative | 0.002 | 0.08 | 0.1976 |
Brugia malayi | flavodoxin family protein | 0.002 | 0.08 | 0.08 |
Trypanosoma brucei | apurinic/apyrimidinic endonuclease, putative | 0.0019 | 0.0747 | 0.1845 |
Trichomonas vaginalis | cat eye syndrome critical region protein 2, cscr2, putative | 0.0044 | 0.2494 | 0.8015 |
Brugia malayi | Papain family cysteine protease containing protein | 0.0017 | 0.0596 | 0.0596 |
Onchocerca volvulus | 0.0017 | 0.0596 | 1 | |
Loa Loa (eye worm) | FAD binding domain-containing protein | 0.0032 | 0.168 | 0.1519 |
Trichomonas vaginalis | Clan CA, family C1, cathepsin L-like cysteine peptidase | 0.0017 | 0.0596 | 0.1914 |
Plasmodium vivax | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0019 | 0.0747 | 0.24 |
Echinococcus granulosus | cathepsin l cysteine peptidase | 0.0017 | 0.0596 | 0.0614 |
Trichomonas vaginalis | Clan CA, family C1, papain-like cysteine peptidase | 0.0017 | 0.0596 | 0.1914 |
Giardia lamblia | Nitric oxide synthase, inducible | 0.0046 | 0.2686 | 1 |
Onchocerca volvulus | 0.0017 | 0.0596 | 1 | |
Echinococcus multilocularis | NADPH cytochrome P450 reductase | 0.0052 | 0.3112 | 0.3112 |
Echinococcus multilocularis | cathepsin l cysteine peptidase | 0.0017 | 0.0596 | 0.0596 |
Trypanosoma cruzi | cysteine peptidase, putative | 0.0017 | 0.0596 | 0.1472 |
Loa Loa (eye worm) | exodeoxyribonuclease III family protein | 0.0019 | 0.0747 | 0.0568 |
Loa Loa (eye worm) | Papain cysteine protease/cathepsin propeptide inhibitor-containing protein | 0.0017 | 0.0596 | 0.0414 |
Loa Loa (eye worm) | flavodoxin family protein | 0.002 | 0.08 | 0.0622 |
Mycobacterium tuberculosis | Probable exodeoxyribonuclease III protein XthA (exonuclease III) (EXO III) (AP endonuclease VI) | 0.0019 | 0.0747 | 0.5 |
Trichomonas vaginalis | Clan CA, family C1, cathepsin L-like cysteine peptidase | 0.0017 | 0.0596 | 0.1914 |
Trypanosoma brucei | S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase, putative | 0.002 | 0.08 | 0.1976 |
Plasmodium falciparum | nitric oxide synthase, putative | 0.0052 | 0.3112 | 1 |
Trypanosoma cruzi | cysteine peptidase, putative | 0.0065 | 0.4047 | 1 |
Echinococcus multilocularis | gcn5proteinral control of amino acid synthesis | 0.0148 | 1 | 1 |
Plasmodium vivax | NADPH-cytochrome p450 reductase, putative | 0.0052 | 0.3112 | 1 |
Trichomonas vaginalis | NADPH cytochrome P450, putative | 0.002 | 0.08 | 0.257 |
Echinococcus granulosus | cathepsin l1 | 0.0011 | 0.019 | 0.0195 |
Brugia malayi | FAD binding domain containing protein | 0.0052 | 0.3112 | 0.3112 |
Trypanosoma cruzi | cruzipain precursor, putative | 0.0065 | 0.4047 | 1 |
Plasmodium vivax | hypothetical protein, conserved | 0.002 | 0.08 | 0.257 |
Trypanosoma cruzi | NADPH--cytochrome P450 reductase, putative | 0.002 | 0.08 | 0.1976 |
Plasmodium vivax | vivapain-2 | 0.0017 | 0.0596 | 0.1914 |
Onchocerca volvulus | Cathepsin F homolog | 0.0017 | 0.0596 | 1 |
Trypanosoma cruzi | NADPH-dependent FMN/FAD containing oxidoreductase, putative | 0.0052 | 0.3112 | 0.7689 |
Plasmodium falciparum | NADPH--cytochrome P450 reductase, putative | 0.002 | 0.08 | 0.257 |
Echinococcus multilocularis | cysteine protease | 0.0017 | 0.0596 | 0.0596 |
Entamoeba histolytica | type A flavoprotein, putative | 0.002 | 0.08 | 0.358 |
Trichomonas vaginalis | Clan CA, family C1, cathepsin L-like cysteine peptidase | 0.0017 | 0.0596 | 0.1914 |
Brugia malayi | cathepsin L-like precursor | 0.0011 | 0.019 | 0.019 |
Trichomonas vaginalis | Clan CA, family C1, cathepsin L-like cysteine peptidase | 0.0017 | 0.0596 | 0.1914 |
Entamoeba histolytica | cysteine proteinase, putative | 0.0011 | 0.019 | 0.0848 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.